Pharma Industry News

A better pill from China: Chinese pharma firms target the global market

Written by David Miller

Print section
Print Rubric: 

Chinese pharma firms are starting to develop new drugs for the global market

Print Headline: 

A better pill from China

Print Fly Title: 

The pharma business

UK Only Article: 
standard article

Issue: 

The global economy enjoys a synchronised upswing

Fly Title: 

A better pill from China

Location: 

SHANGHAI

Main image: 

The way things were

The way things were

WALK into the Shanghai laboratories of Chi-Med, a biotech firm, and you encounter the sort of shiny, cutting-edge facilities common in any major pharma company in America, Europe or Japan. Chi-Med has just had positive results in a late-stage trial of its drug for colorectal cancer, which is called Fruquintinib. If the drug is approved both in China and in Western markets it could be the very first prescription drug …Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]